Two new phorbol esters, NPB-11 (12-O-methoxymethylphorbol-13-decanoate) and NPB-15 (12-O-benzyloxymethylphorbol-13-decanoate) were synthesized. The compounds exhibited potent anti-HIV-1 activity and low cytotoxicity in MT-4 cells by MTT assay even at a high concentration [50% cytotoxic concentrations (CC50) were 8.32 and 4.39 μg/ml, respectively]. Two inhibitors strongly suppressed HIV-1 (IIIB strain) replication in MT-4 cells with a 50% effective concentration (EC50) of 1.3 and 0.27 ng/ml, respectively. NPB-11 efficiently blocked replication of both X4 and R5 HIV-1 in PHA-activated peripheral blood mononuclear cells and MT-4 cells as revealed by p24 assay. The antiviral activity appeared to be mediated, at least partially, by the down-regulation of the expression of CD4 and the HIV-1 co-receptors, CXCR4 and CCR5. The compounds were also capable of selectively up-regulating HIV-1 expression in a variety of latently infected cell lines and inducing cell death in HIV-1 infected cells. The effect of NPBs on the induction of HIV-1 was specifically blocked by nontoxic doses of a protein kinase C blocker, staurosporine. NPB-11 blocked the spread of HIV-1 released from latently infected ACH-2 cells to MT-4 cells in a co-culture system. When combined with AZT, NPB-11 synergistically inhibited HIV-1 replication in MTT assay using MT-4 cells. These data suggest that these agents might be useful in reducing persistent viral reservoirs in patients and as adjuvant therapy in patients treated with HAART.
AritaYO'DriscollKR & WeinsteinIB (1994) Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate. International Journal of Cancer56: 229–235.
3.
BiancottoAGrivelJCGondois-ReyFBettendrofferLVigneRBrownSMargolisLB & HirschI (2004) Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. Journal of Virology78: 10507–10515.
4.
BocklandtSBlumbergPM & HamerDH (2003) Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate. Antiviral Research59: 89–98.
5.
ButeraSTPerezVLBesanskyNJChanWCWuBYNabelGJ & FolksTM (1991) Extrachromosomal human immunodeficiency virus type-1 DNA can initiate a spreading infection of HL-60 cells. Journal of Cellular Biochemistry45: 366–373.
6.
ChowdhuryIHKoyanagiYKobayashiSHamamotoYYoshiyamaHYoshidaT & YamamotoN (1990) The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: Possible involvement of protein kinase C pathway. Virology176: 126–132.
7.
ChunTWCarruthLFinziDShenXDiGiuseppeJATaylorHHermankovaMChadwickKMargolickJQuinnTCKuoYHBrookmeyerRZeigerMABarditch-CrovoP & SilicianoRF (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature387: 183–188.
8.
ChunTWJustementJSLempickiRAYangJDennisGJrHallahanCWSanfordCPandyaPLiuSMcLaughlinMEhlerLAMoirS & FauciAS (2003) Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proceedings of the National Academy of Sciences of the United States of America100: 1908–1913. Epub 2003 Jan 27.
9.
ClouseKAPowellDWashingtonIPoliGStrebelKFarrarWBarstadPKovacsJFauciAS & FolksTM (1989) Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. Journal of Immunology142: 431–438.
10.
DaveyRTJrBhatNYoderCChunTWMetcalfJADewarRNatarajanVLempickiRAAdelsbergerJWMillerKDKovacsJAPolisMAWalkerREFalloonJMasurHGeeDBaselerMDimitrovDSFauciAS & LaneHC (1999) HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proceedings of the National Academy of Sciences of the United States of America96: 15109–15114.
11.
FinziDBlanksonJSilicianoJDMargolickJBChadwickKPiersonTSmithKLisziewiczJLoriFFlexnerCQuinnTCChaissonRERosenbergEWalkerBGangeSGallantJ & SilicianoRF (1999) Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine5: 512–517.
12.
FinziDHermankovaMPiersonTCarruthLMBuckCChaissonREQuinnTCChadwickKMargolickJBrookmeyerRGallantJMarkowitzMHoDDRichmanDD & SilicianoRF (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science278: 1295–1300.
13.
FolksTMJustementJKinterADinarelloCA & FauciAS (1987) Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science238: 800–802.
14.
FolksTMClouseKAJustementJRabsonADuhEKehrlJH & FauciAS (1989) Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proceedings of the National Academy of Sciences of the United States of America86: 2365–2368.
15.
GulakowskiRJMcMahonJBBuckheitRWJrGustafsonKR & BoydMR (1997) Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV). Antiviral Research33: 87–97.
16.
GustafsonKRCardellinaJH2ndMcMahonJBGulakowskiRJIshitoyaJSzallasiZLewinNEBlumbergPMWeislowOS & BeutlerJA (1992) A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. Journal of Medicinal Chemistry35: 1978–1986.
17.
HamamotoYHayashidaYKobayashiSTamaokiTYamamotoN & KobayashiN (1989) Comparison of effects of protein kinase C inhibitors on phorbol ester-induced CD4 down-regulation and augmentation of human immunodeficiency virus replication in human T cell lines. Biochemical and Biophysical Research Communications164: 339–344.
18.
HanZTZhuXXYangRYSunJZTianGFLiuXJCaoGSNewmarkHLConneyAH & ChangRL (1998a) Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: Preliminary studies on therapeutic efficacy and toxicity. Proceedings of the National Academy of Sciences of the United States of America95: 5357–5361.
19.
HanZTTongYKHeLMZhangYSunJZWangTYZhangHCuiYLNewmarkHLConneyAH & ChangRL (1998b) 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced increase in depressed white blood cell counts in patients treated with cytotoxic cancer chemotherapeutic drugs. Proceedings of the National Academy of Sciences of the United States of America95: 5362–5365.
20.
HaradaSYamamotoN & FujikiH (1988) Lysis of human immunodeficiency virus infected cells by TPA-type and non-TPA type tumor promoters. AIDS Research and Human Retroviruses4: 99–105.
21.
KitanoKBaldwinGCRainesMA & GoldeDW (1990) Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood76: 1980–1988.
22.
KorinYDBrooksDGBrownSKorotzerA & ZackJA (2002) Effects of prostratin on T-cell activation and human immunodeficiency virus latency. Journal of Virology76: 8118–8123.
23.
KulkoskyJCulnanDMRomanJDornadulaGSchnellMBoydMR & PomerantzRJ (2001) Prostratin: Activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood98: 3006–3015.
24.
MatsuyaYYuZYamamotoNMoriMSaitoHTakeuchiMItoM & NemotoH (2005) Synthesis of new phorbol derivatives having ethereal side chain and evaluation of their anti-HIV activity. Bioorganic & Medicinal Chemistry13: 4383–4388.
25.
MatsuyamaTHamamotoYSomaGMizunoDYamamotoN & KobayashiN (1989) Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): Enhancement of HIV replication. Journal of Virology63: 2504–2509.
26.
NeumannAUTubianaRCalvezVRobertCLiTSAgutHAutranB & KatlamaC (1999) HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS13: 677–683.
27.
PauwelsRBalzariniJBabaMSnoeckRScholsDHerdewijnPDesmyterJ & De ClercqE (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods20: 309–321.
28.
RamratnamBMittlerJEZhangLBodenDHurleyAFangFMacKenCAPerelsonASMarkowitzM & HoDD (2000) The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nature Medicine6: 82–85.
29.
SharkeyMETeoIGreenoughTSharovaNLuzuriagaKSullivanJLBucyRPKostrikisLGHaaseAVeryardCDavaroRECheesemanSHDalyJSBovaCEllisonRT3rdMadyBLaiKKMoyleGNelsonMGazzardBShaunakS & StevensonM (2000) Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nature Medicine6: 76–81.
30.
ShimizuNNaoeTKawazoeYSakagamiHNakashimaHMurakamiT & YamamotoN (1993) Lignified materials as medicinal resources. VI. Anti-HIV activity of dehydrogenation polymer of p-coumaric acid, a synthetic lignin, in a quasi-in-vivo assay system as an intermediary step to clinical trials. Biological & Pharmaceutical Bulletin16: 434–436.
31.
SilicianoJDKajdasJFinziDQuinnTCChadwickKMargolickJBKovacsCGangeSJ & SilicianoRF (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature Medicine9: 727–728.
32.
StrainMCGunthardHFHavlirDVIgnacioCCSmithDMLeigh-BrownAJMacAranasTRLamRYDalyOAFischerMOpravilMLevineHBachelerLSpinaCARichmanDD & WongJK (2003) Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence. Proceedings of the National Academy of Sciences of the United States of America100: 4819–4824.
33.
StrairRKSchaarDGoodellLAisnerJChinKVEidJSenzonRCuiXXHanZTKnoxBRabsonABChangR & ConneyA (2002) Administration of a phorbol ester to patients with hematological malignancies: Preliminary results from a Phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate. Clinical Cancer Research8: 2512–2518.
34.
SwinglerSBrichacekBJacqueJMUlichCZhouJ & StevensonM (2003) HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature424: 213–219.
35.
TsaiJCTsaiS & ChangWC (2004) Effect of ethanol extracts of three Chinese medicinal plants with laxative properties on ion transport of the rat intestinal epithelia. Biological & Pharmaceutical Bulletin27: 162–165.
36.
WongJKHezarehMGunthardHFHavlirDVIgnacioCCSpinaCA & RichmanDD (1997a) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science278: 1291–1295.
37.
WongJKGunthardHFHavlirDVZhangZQHaaseATIgnacioCCKwokSEminiE & RichmanDD (1997b) Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proceedings of the National Academy of Sciences of the United States of America94: 12574–12579.
38.
ZhengXChangRLCuiXXAvilaGELeeSLuYPLouYRShihWJLinYReuhlKNewmarkHRabsonA & ConneyAH (2004) Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice. Cancer Research64: 1811–1820.
